摘要
近些年随着社会老龄化的加剧,冠心病为人类社会带来了极大的经济负担。而根据人们对中医药的研究发现,中医药在治疗冠心病方面具有其独特的优势,因此中药药理学也逐渐受到人们的关注。笔者通过归纳整理近年来冠心病药物治疗和中药药理方面关于冠心病研究治疗进展,阐述了中药药理学包括单味药和复方药剂在临床中治疗冠心病的研究进展及其所取得的临床研究成果,并对中药药理学应用于冠心病研究治疗前景作了总结与展望。
Coronary heart disease(CHD)brings enormous economic burden to human society along with the social aging intensifies recently.TCM has its unique advantages in the treatment of CHD,therefore pharmacology of TCM has been paid more attentionto.This study reviewed the research progress of CHD related to treatment and TCM pharmacology,it elaborated a single drug and compound formula in the treatment of CHD and the clinical research results.It also summarized and prospected the application of TCM pharmacology in the research and treatment of CHD.
作者
王姿了
李苗
职利琴
WANG Ziliao;LI Miao;ZHI Liqin(Shaanxi University of Chinese Medicine,Xianyang 712046,China;Famous Doctor’s Studio of Xi’an No.5 Hospital,Xi’an 710000,China)
出处
《中医药学报》
CAS
2019年第6期114-117,共4页
Acta Chinese Medicine and Pharmacology
基金
陕西省中医管理局中医药科研课题(LCMS062)
陕西省科学技术厅项目(2018SF-278)
关键词
冠心病
中药药理学
复方
单味药
Coronary heart disease
Pharmacology of TCM
Compound formula
A single drug
